QSAM begins patient enrolment for bone cancer therapy trial
QSAM Biosciences has commenced subject enrolment for its Phase I clinical trial of its therapy CycloSam (Samarium-153 DOTMP) to treat bone cancer, after activating its…
Filing Analytics
Clinical Sector Filing Sentiment Score (Last 12 months)
Clinical Sector Trending Regions in Company Filings (Last 12 months)
Top 10 Clinical Companies Filing Themes - 2020 Vs. 2019 and Top Companies in 2020
| Top 10 Themes | 2020 Rank | 2019 Rank | Top 5 Companies with Themes Mentions in 2020 |
|---|---|---|---|
| Geopolitics | 1 | 1 | BeiGene (Beijing) Co Ltd | Hutchmed China Ltd | F. Hoffmann-La Roche Ltd | AstraZeneca Plc | FibroGen Inc |
| Demographics | 2 | 2 | Moderna Inc | Axcella Health Inc | Aurinia Pharmaceuticals Inc | Denali Therapeutics Inc | Allogene Therapeutics Inc |
| M&A | 3 | 3 | Alexion Pharmaceuticals Inc | Akebia Therapeutics Inc | Pfizer Inc | Charles River Laboratories International Inc | Biogen Inc |
| China Impact | 4 | 4 | Hutchmed China Ltd | BeiGene (Beijing) Co Ltd | FibroGen Inc | Athenex Inc | F. Hoffmann-La Roche Ltd |
| Cybersecurity | 5 | 6 | Alnylam Pharmaceuticals Inc | BioMarin Pharmaceutical Inc | Pfizer Inc | Vir Biotechnology Inc | Denali Therapeutics Inc |
| Emerging Economies | 6 | 5 | Cipla Ltd | Sun Pharmaceutical Industries Ltd | Apollo Hospitals Enterprise Ltd | Jubilant Pharmova Ltd | AstraZeneca Plc |
| Climate Change | 7 | 7 | Novartis AG | Cipla Ltd | Daiichi Sankyo Co Ltd | Merck KGaA | AstraZeneca Plc |
| Workplace Safety | 8 | 8 | Aspen Pharmacare Holdings Ltd | Merck KGaA | Lumos Pharma Inc | Chugai Pharmaceutical Co Ltd | Axcella Health Inc |
| Big Data | 9 | 9 | F. Hoffmann-La Roche Ltd | Moderna Inc | Shionogi & Co Ltd | Bristol-Myers Squibb Co | BioXcel Therapeutics Inc |
| Artificial Intelligence | 10 | 10 | F. Hoffmann-La Roche Ltd | BioXcel Therapeutics Inc | Moderna Inc | Mateon Therapeutics Inc | Apollo Hospitals Enterprise Ltd |
Clinical Sector Filing Mentions (Last 12 months)
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
Revelation Biosciences begins Phase IIb trial of H3N2 influenza therapy
Revelation Biosciences has commenced a Phase IIb study of its intranasal drop solution, REVTx-99, in healthy individuals to prevent H3N2 influenza (influenza A). The solution…
Sobi and Selecta Biosciences complete enrolment for gout therapy trial
Swedish Orphan Biovitrum (Sobi) and Selecta Biosciences have completed the enrolment of participants for the DISSOLVE I study to assess…
GreenLight and IAVI partner for Phase I trial of Covid-19 vaccine in Africa
GreenLight Biosciences has collaborated with non-profit scientific research organisation International AIDS Vaccine Initiative (IAVI) for a Covid-19 vaccine trial in…
Longeveron to explore cell-based therapy in trial of older and frail subjects
Longeveron has signed a sponsored clinical research agreement with Japan’s National Center for Geriatrics and Gerontology (NCGG) and Juntendo University…
Axial Therapeutics begins dosing in Phase IIb autism therapy trial
Axial Therapeutics has dosed the first participants in an international Phase IIb clinical trial of a gut-targeted molecular therapy, AB-2004,…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
